Latest News
Transforming Crohn’s Disease
At INTERCEPT, we are transforming the landscape of Crohn’s disease research by shifting from reactive symptom management to proactive early detection and prevention by using biomarkers to identify individuals at risk before symptoms develop, making diagnosis earlier than early.


Families at the centre
Families are at the heart of our research and our aim to pioneer a future without Crohn’s disease, impacting and improving the lives of generations to come. The INTERCEPT project aims to verify and clinically validate a panel of biomarkers and build a blood risk score that can identify individuals with a high risk of developing Crohn’s disease within five years after initial evaluation. Find out more about our study and how you can be a part of it.
Contact us
If you are a researcher, industry representative, a first-degree relative of a person living with Crohn’s disease or interested in knowing more about our research and clinical trials, please feel free to reach out to us.



